What if you could identify high risk patients at the earliest stage of their cardiovascular disease - would you treat them differently?


EndoPAT - A Personalized Window to Your Patients’ Arterial Health

EndoPAT only FDA-cleared non-invasive assessment of Endothelial Dysfunction (arterial health), is a functional test for early detection of underlying disease progression. It offers both prevention of re-admission, as well as early prevention of diseases. Endothelial Dysfunction is the earliest detectable stage of atherosclerosis and cardiovascular disease.  Read More

EndoPAT Resources
  FAQ Downloads Videos